UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030687
Receipt number R000035038
Scientific Title Relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde
Date of disclosure of the study information 2018/01/05
Last modified on 2020/06/15 09:06:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde

Acronym

Relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde

Scientific Title

Relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde

Scientific Title:Acronym

Relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde

Region

Japan


Condition

Condition

A healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To elucidate relationship between ALDH2 and ADH1B phenotypes and circadian variation of endogenous ethanol and acetaldehyde

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Breath endogenous alcohol and acetaldehyde concentrations

Key secondary outcomes

ADH1B and ALDH2 genotypes


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention is straight for 2 days. A subject is sampled his/her breath 4 times for the 2 days; on rising (5:00~7:00), before lunch (11:00~13:00), before dinner (17:00~19:00) and before retiring (23:00~25:00). Sampling is taken after at least 3 h of fasting and 1 h of washing mouth. A subject abstains from alcohol during intervention.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

・20<= years-old
・Male and Female
・A person who is provided sufficient explanations about this study and consented to it in writing by his/her own free will

Key exclusion criteria

・an inappropriate person for this study
・a person who has any airway diseases or liver diseases

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Ayako
Middle name
Last name Himemiya-Hakucho

Organization

Graduate School of Medicine, Yamaguchi University

Division name

Department of Legal Medicine

Zip code

7558505

Address

Minami-kogushi 1-1-1, Ube, Yamaguchi, JAPAN

TEL

0836-22-2234

Email

fujimiya@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Ayako
Middle name
Last name Himemiya-Hakucho

Organization

Graduate School of Medicine, Yamaguchi University

Division name

Department of Legal Medicine

Zip code

7558505

Address

Minami-kogushi 1-1-1, Ube, Yamaguchi, JAPAN

TEL

0836-22-2234

Homepage URL


Email

haku.a@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center For Clinical Research, Yamaguchi University Hospital

Address

Minami-kogushi 1-1-1, Ube, Yamaguchi, JAPAN

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 12 Month 27 Day

Date of IRB

2017 Year 12 Month 27 Day

Anticipated trial start date

2018 Year 01 Month 10 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 01 Month 05 Day

Last modified on

2020 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035038


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name